Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 804659, 12 pages
http://dx.doi.org/10.1155/2015/804659
Research Article

A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion

1Dipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, Via P. Giuria 9, 10125 Torino, Italy
2Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, Università di Torino, Via Nizza 52, 10126 Torino, Italy
3ININCA-CONICET, Buenos Aires, Argentina

Received 15 December 2014; Accepted 13 February 2015

Academic Editor: Trevor A. Mori

Copyright © 2015 Fausto Chiazza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Fausto Chiazza, Konstantin Chegaev, Mara Rogazzo, et al., “A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 804659, 12 pages, 2015. https://doi.org/10.1155/2015/804659.